ENVALITH
キッセイ薬品工業株式会社 logo

KISSEI PHARMACEUTICAL CO., LTD.

4547Prime MarketPharmaceuticals

キッセイ薬品工業株式会社 logo
KISSEI PHARMACEUTICAL CO., LTD.4547
Reference Indicators

Market Cap

1,959¥100M

P/E (Forecast)

P/B

0.8x

Dividend Yield (Forecast)

4.04%

ROE

6.3%

EV/EBITDA

97.9x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
65,38167,49375,57988,33097,406
Cost of Sales
34,14335,11838,23844,26551,587
Gross Profit
31,23832,37437,34144,06545,818
SG&A Expenses
32,64033,50333,32438,29148,745
Operating Income
-1,402-1,1294,0175,773-2,927
Non-operating Income
2,0921,8372,3291,5422,268
Non-operating Expenses
127109203341504
Ordinary Income
5625986,1426,974-1,162
Extraordinary Income
16,60113,0868,34912,03318,248
Extraordinary Losses
6564433,398195
Pre-tax Income
16,50713,68014,44915,61016,891
Income Taxes
3,4753,0463,1593,6342,930
Net Income
12,92110,52811,16011,96113,779
EBITDA
2,3282,9808,27110,3881,717
Gross Margin
47.8%48.0%49.4%49.9%47.0%
Operating Margin
-2.1%-1.7%5.3%6.5%-3.0%
ROA
5.4%4.8%4.3%4.9%5.0%
ROE
6.1%5.3%5.4%5.6%6.3%
Segment Performance
Unit: ¥M
2026
SegmentNet SalesOperating IncomeOperating Margin
医薬品77,950-4,524-5.8%
情報サービス14,2371,1027.7%
建設・施設メンテナンス4,33159513.7%
物品販売88613615.3%